UnknownPhase 3NCT02208427

Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Taiwan University Hospital
Principal Investigator
Jann-Yuan Wang, MD. PhD.
National Taiwan University Hospital
Intervention
Rifapentine and Isoniazid for 3 months(drug)
Enrollment
283 enrolled
Eligibility
12 years · All sexes
Timeline
2014 – 2016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02208427 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials